PL1784409T3 - Podstawione amidy kwasów tienopirolokarboksylowych, amidy kwasów pirolotiazolokarboksylowych i pokrewne analogi jako inhibitory kinazy kazeinowej I epsilon - Google Patents

Podstawione amidy kwasów tienopirolokarboksylowych, amidy kwasów pirolotiazolokarboksylowych i pokrewne analogi jako inhibitory kinazy kazeinowej I epsilon

Info

Publication number: PL1784409T3
Authority: PL; Poland
Prior art keywords: carboxylic acid; acid amides; pyrrolothiazole; epsilon; inhibitors
Prior art date: 2004-08-19

Application number

PL05826812T

Other languages

English (en)

Inventor

David Marc Fink

Yulin Chiang

Nicola Dawn Collar

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-19

Filing date

2005-08-18

Publication date

2010-10-29

2005-08-18 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2010-10-29 Publication of PL1784409T3 publication Critical patent/PL1784409T3/pl

Links

YRVMMDZANCTYNL-UHFFFAOYSA-N 2h-pyrrolo[2,3-d][1,3]thiazole-2-carboxamide Chemical class C1=NC2=NC(C(=O)N)SC2=C1 YRVMMDZANCTYNL-UHFFFAOYSA-N 0.000 title 1
102000008122 Casein Kinase I Human genes 0.000 title 1
108010049812 Casein Kinase I Proteins 0.000 title 1
150000001732 carboxylic acid derivatives Chemical class 0.000 title 1
239000003112 inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Anesthesiology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Peptides Or Proteins (AREA)

PL05826812T 2004-08-19 2005-08-18 Podstawione amidy kwasów tienopirolokarboksylowych, amidy kwasów pirolotiazolokarboksylowych i pokrewne analogi jako inhibitory kinazy kazeinowej I epsilon PL1784409T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US60334704P	2004-08-19	2004-08-19
PCT/US2005/029383 WO2006021000A2 (en)	2004-08-19	2005-08-18	Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon
EP05826812A EP1784409B1 (en)	2004-08-19	2005-08-18	Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i epsilon

Publications (1)

Publication Number	Publication Date
PL1784409T3 true PL1784409T3 (pl)	2010-10-29

Family

ID=35695546

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05826812T PL1784409T3 (pl)	2004-08-19	2005-08-18	Podstawione amidy kwasów tienopirolokarboksylowych, amidy kwasów pirolotiazolokarboksylowych i pokrewne analogi jako inhibitory kinazy kazeinowej I epsilon

Country Status (30)

Country	Link
US (2)	US7393867B2 (pl)
EP (1)	EP1784409B1 (pl)
JP (1)	JP4869232B2 (pl)
KR (1)	KR20070045263A (pl)
CN (1)	CN100562521C (pl)
AR (1)	AR051008A1 (pl)
AT (1)	ATE471326T1 (pl)
AU (1)	AU2005272584B2 (pl)
BR (1)	BRPI0514419A (pl)
CA (1)	CA2577879C (pl)
CY (1)	CY1110775T1 (pl)
DE (1)	DE602005021889D1 (pl)
DK (1)	DK1784409T3 (pl)
ES (1)	ES2347166T3 (pl)
GT (1)	GT200500215A (pl)
HR (1)	HRP20100475T1 (pl)
IL (1)	IL181158A0 (pl)
JO (1)	JO2629B1 (pl)
MY (1)	MY139831A (pl)
PA (1)	PA8642801A1 (pl)
PE (1)	PE20060630A1 (pl)
PL (1)	PL1784409T3 (pl)
PT (1)	PT1784409E (pl)
RS (1)	RS51413B (pl)
RU (1)	RU2403257C2 (pl)
SI (1)	SI1784409T1 (pl)
SV (1)	SV2006002190A (pl)
TW (1)	TWI372149B (pl)
UY (1)	UY29077A1 (pl)
WO (1)	WO2006021000A2 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NZ548212A (en)	2003-12-29	2010-07-30	Sepracor Inc	Pyrrole and pyrazole DAAO inhibitors
US8053603B2 (en)	2006-01-06	2011-11-08	Sunovion Pharmaceuticals Inc.	Tetralone-based monoamine reuptake inhibitors
KR101294014B1 (ko)	2006-01-06	2013-08-09	선오비온 파마슈티컬스 인코포레이티드	모노아민 재흡수 저해제로서의 시클로알킬아민
DK2816024T3 (en)	2006-03-31	2017-10-30	Sunovion Pharmaceuticals Inc	CHIRALE AMINER
US7884124B2 (en)	2006-06-30	2011-02-08	Sepracor Inc.	Fluoro-substituted inhibitors of D-amino acid oxidase
US7902252B2 (en)	2007-01-18	2011-03-08	Sepracor, Inc.	Inhibitors of D-amino acid oxidase
EP1955699A1 (en) *	2007-02-08	2008-08-13	Boehringer Ingelheim Pharma GmbH & Co. KG	Use of flibanserin for the treatment of insomnia
MX2009012685A (es)	2007-05-31	2009-12-14	Sepracor Inc	Cicloalquilaminas sustituidas con fenilo como inhibidores de la reabsorcion de monoamina.
JP4748823B2 (ja) *	2009-02-12	2011-08-17	株式会社ファルマデザイン	カゼインキナーゼ１δ及びカゼインキナーゼ１ε阻害剤
UA106082C2 (uk) *	2009-05-28	2014-07-25	Вертекс Фармасьютікалз Інкорпорейтед	АМІНОПІРАЗОЛ ТРИАЗОЛОТІАДІАЗОЛЬНІ ІНГІБІТОРИ ПРОТЕЇНКІНАЗИ c-МЕТ
MX2012004997A (es) *	2009-10-28	2012-06-12	Pfizer	Derivados de imidazol como inhibidores de la caseina quinasa.
DE102009058280A1 (de) *	2009-12-14	2011-06-16	Merck Patent Gmbh	Thiazolderivate
CN104803997A (zh) *	2010-08-09	2015-07-29	株式会社创药分子设计	酪蛋白激酶1δ及酪蛋白激酶1ε抑制剂
CN109748927A (zh) *	2017-11-03	2019-05-14	上海交通大学医学院附属瑞金医院	杂芳基酰胺类化合物、其制备方法、药用组合物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9702001D0 (sv) *	1997-05-28	1997-05-28	Astra Pharma Prod	Novel compounds
KR100722176B1 (ko) *	1999-06-08	2007-05-29	아벤티스 파마슈티칼스 인크.	일주기 리듬 단백질을 변화시키기 위한 스크리닝 방법
CN100439367C (zh) *	2003-12-11	2008-12-03	安万特药物公司	作为酪蛋白激酶Iε抑制剂的取代的1H-吡咯并[3,2-b、3,2-c和2,3-c]吡啶-2-甲酰胺以及相关类似物

2005
- 2005-07-18 JO JO2005104A patent/JO2629B1/en active
- 2005-08-09 GT GT200500215A patent/GT200500215A/es unknown
- 2005-08-09 SV SV2005002190A patent/SV2006002190A/es not_active Application Discontinuation
- 2005-08-16 AR ARP050103439A patent/AR051008A1/es unknown
- 2005-08-17 PE PE2005000956A patent/PE20060630A1/es not_active Application Discontinuation
- 2005-08-18 CN CNB2005800269958A patent/CN100562521C/zh not_active Expired - Fee Related
- 2005-08-18 PT PT05826812T patent/PT1784409E/pt unknown
- 2005-08-18 JP JP2007528007A patent/JP4869232B2/ja not_active Expired - Fee Related
- 2005-08-18 BR BRPI0514419-1A patent/BRPI0514419A/pt not_active Application Discontinuation
- 2005-08-18 CA CA2577879A patent/CA2577879C/en not_active Expired - Fee Related
- 2005-08-18 WO PCT/US2005/029383 patent/WO2006021000A2/en not_active Ceased
- 2005-08-18 RS RSP-2010/0401A patent/RS51413B/sr unknown
- 2005-08-18 SI SI200531094T patent/SI1784409T1/sl unknown
- 2005-08-18 PL PL05826812T patent/PL1784409T3/pl unknown
- 2005-08-18 EP EP05826812A patent/EP1784409B1/en not_active Expired - Lifetime
- 2005-08-18 DK DK05826812.9T patent/DK1784409T3/da active
- 2005-08-18 AU AU2005272584A patent/AU2005272584B2/en not_active Ceased
- 2005-08-18 HR HR20100475T patent/HRP20100475T1/hr unknown
- 2005-08-18 KR KR1020077003865A patent/KR20070045263A/ko not_active Abandoned
- 2005-08-18 AT AT05826812T patent/ATE471326T1/de active
- 2005-08-18 RU RU2007109812/04A patent/RU2403257C2/ru not_active IP Right Cessation
- 2005-08-18 MY MYPI20053879A patent/MY139831A/en unknown
- 2005-08-18 DE DE602005021889T patent/DE602005021889D1/de not_active Expired - Lifetime
- 2005-08-18 ES ES05826812T patent/ES2347166T3/es not_active Expired - Lifetime
- 2005-08-19 TW TW094128282A patent/TWI372149B/zh not_active IP Right Cessation
- 2005-08-19 UY UY29077A patent/UY29077A1/es not_active Application Discontinuation
- 2005-08-19 PA PA20058642801A patent/PA8642801A1/es unknown
2007
- 2007-02-04 IL IL181158A patent/IL181158A0/en unknown
- 2007-02-13 US US11/674,349 patent/US7393867B2/en not_active Expired - Lifetime
2008
- 2008-05-22 US US12/125,450 patent/US7652046B2/en not_active Expired - Lifetime
2010
- 2010-09-09 CY CY20101100823T patent/CY1110775T1/el unknown

Also Published As

Publication number	Publication date
HK1105198A1 (en)	2008-02-06
PE20060630A1 (es)	2006-08-03
CN100562521C (zh)	2009-11-25
BRPI0514419A (pt)	2008-06-10
AR051008A1 (es)	2006-12-13
JP4869232B2 (ja)	2012-02-08
US7393867B2 (en)	2008-07-01
RS51413B (sr)	2011-02-28
PA8642801A1 (es)	2006-05-16
JP2008510712A (ja)	2008-04-10
ES2347166T3 (es)	2010-10-26
DE602005021889D1 (en)	2010-07-29
JO2629B1 (en)	2012-06-24
RU2007109812A (ru)	2008-09-27
CY1110775T1 (el)	2015-06-10
WO2006021000A2 (en)	2006-02-23
US20070299112A1 (en)	2007-12-27
HRP20100475T1 (hr)	2010-10-31
AU2005272584A1 (en)	2006-02-23
GT200500215A (es)	2006-03-27
US7652046B2 (en)	2010-01-26
CN101001861A (zh)	2007-07-18
TWI372149B (en)	2012-09-11
MY139831A (en)	2009-10-30
AU2005272584B2 (en)	2010-11-11
US20080227822A1 (en)	2008-09-18
PT1784409E (pt)	2010-09-06
ATE471326T1 (de)	2010-07-15
UY29077A1 (es)	2006-03-31
TW200621788A (en)	2006-07-01
SV2006002190A (es)	2006-05-24
KR20070045263A (ko)	2007-05-02
CA2577879C (en)	2011-07-12
SI1784409T1 (sl)	2010-10-29
WO2006021000A3 (en)	2006-06-15
IL181158A0 (en)	2007-07-04
RU2403257C2 (ru)	2010-11-10
EP1784409A2 (en)	2007-05-16
CA2577879A1 (en)	2006-02-23
DK1784409T3 (da)	2010-09-27
EP1784409B1 (en)	2010-06-16

Publication	Publication Date	Title
IL181158A0 (en)	2007-07-04	Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase i?á
IL181169A0 (en)	2007-07-04	Trifluoromethyl substituted benzamides as kinase inhibitors
IL186526A0 (en)	2008-01-20	Substituted amide derivatives as protein kinase inhibitors
ZA200704106B (en)	2009-09-30	Inhibitors of c-fms kinase
IL198487A0 (en)	2010-02-17	2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
IL181720A0 (en)	2007-07-04	Bicyclic amides as kinase inhibitors
IL183279A0 (en)	2007-09-20	Oxadiazole derivatives as dgat inhibitors
EP1737845A4 (en)	2010-07-21	DISPLAY HEMMER OF IL-12 PRODUCTION
IL198398A0 (en)	2010-02-17	2-aminothiazole-4-carboxylic amides as protein kinase inhibitors
PL1711481T5 (pl)	2013-10-31	Krystaliczny monohydrat jako inhibitor kinazy
IL187451A0 (en)	2008-02-09	Oxadiazole derivatives as dgat inhibitors
IL184504A0 (en)	2007-10-31	4-(2,6-dichlorobenzoylamino)-1h-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors
IL183526A0 (en)	2007-09-20	4-(4-(imidazol-4-yl)pyrimidin-2-ylamino)benzamides as cdk inhibitors
PT2225238E (pt)	2014-12-18	Derivados de amidas do ácido 6,7-di-hidro-5h-imidazo[1,2- a]imidazol-3-carboxílico
AU2003271566A8 (en)	2004-03-03	Pyrrolopyrazines as kinase inhibitors
ZA200701942B (en)	2008-10-29	Novel phenylaminopyrimidine derivatives as inhibitors of BCR-ABL kinase
EP1756092A4 (en)	2009-12-02	NEW INHIBITORS OF RHO-KINASEN
IL182735A0 (en)	2007-09-20	Inhibitors of c-fms kinase
AP2076A (en)	2009-12-17	New Heterocyclic carboxylic acid amide derivatives
ZA200700651B (en)	2008-09-25	3-substituted-5-and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase
ZA200709852B (en)	2008-10-29	Spiro-benzimidazoles as inhibitors of gastric acid secretion
IL193671A0 (en)	2009-05-04	Crystalline forms of n-{2-tert-butyl-1-[(4,4-difluorocyclohexyl)methyl]-lh-ben-imidazol-5-yl}ethanesulfonamide salts
ZA200700650B (en)	2008-09-25	Bicyclic amides as kinase inhibitors
ZA200705024B (en)	2010-09-29	Oxadiazole derivatives as DGAT inhibitors
ZA200700751B (en)	2008-08-27	Azalndoles useful as inhibitors of protein kinases